featured
Early Adverse Events Resulting in T-DM1 Dose Adjustments on Survival of HER2+ Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Early Adverse Events Resulting in Ado-Trastuzumab Emtansine Dose Adjustments on Survival Outcomes of HER2+ Advanced Breast Cancer Patients
Breast Cancer Res Treat 2019 Aug 09;[EPub Ahead of Print], E Tang, A Rowland, RA McKinnon, MJ Sorich, AM HopkinsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.